HepaPredict AB
Specialized CRO using 3D liver spheroids for drug toxicity prediction.
Översikt
- 1–4
- Anställda
- 1–2.5milj SEK
- Omsättning
- 2016
- Grundat
Nyckelbeslutsfattare
Volker Lauschke
Co-founder and CEO
Magnus Ingelman-Sundberg
Co-founder and Chairman of the Board
Bo Qwarnström
Member of the Board
Sabine U. Vorrink
Chief Operating Officer (COO)
Beskrivning
HepaPredict AB is a specialized Contract Research Organization (CRO) founded in 2016 as a spin-off from Karolinska Institutet. The company focuses intensely on drug metabolism, toxicity assessment, and drug development services specifically related to liver diseases. Their primary offering revolves...